Welcome to 3i

For US regulatory reasons, US Residents are not to enter this site without the express permission of 3i Group plc, and 3i Group plc is not offering any securities or services in the United States or to US Residents through this site. (The term "US Residents" is defined in the detailed terms and conditions set out in the Terms and conditions page).

I am not a US resident (or I am, but I have 3i Group plc's express permission to use this site) and I accept the terms and conditions.

Terms and conditions

Wilsonhcg 2019 034

Wilson Human Capital Group

  • Sector Services and Software
  • Year invested 2021
  • Location North America
  • Status Current

Wilson Human Capital Group (“WilsonHCG”) is an award-winning global leader in talent solutions. 

Visit wilsonhcg.com

  • WHCG Corporate Headquarters 2
  • Wilsonhcg 2019 104
  • Wilsonhcg 2019 006

Overview

Headquartered in Tampa, Florida, WilsonHCG is a global business with offices throughout North America, Europe and Asia and has operated as a strategic partner to some of the world’s most admired brands in helping them plan and execute on talent acquisition globally.

The company provides a full suite of configurable talent solutions including recruitment process outsourcing (“RPO”), executive search, contingent talent solutions and talent consulting.

WilsonHCG is widely known for its high-performance culture including its core values of collaboration, ownership, integrity, passion and communication. As a result, the company is recognised as a leader by various industry trade associations such as HRO Today, Everest Group, NelsonHall and SIA, including leading the HRO Today Baker’s Dozen Top RPO rankings in recent years. 

How we add value 

WilsonHCG is a strong fit with our investment strategy, with a focus on high quality outsourced services, an increasingly international business, especially across Europe and Asia, and a strong management team.

We have supported the company in the acquisition of Personify, a leading provider of RPO services to the life sciences and healthcare end markets, representing the company’s third acquisition under our ownership. 

The RPO market is expected to benefit following the Covid-19 pandemic as companies increasingly value the superior outcomes, flexibility and efficiency that RPO providers such as WilsonHCG provide their clients. 

We have known the 3i team for a number of years and they have demonstrated a clear commitment to investing in our space. There is a strong cultural fit between our organisations and a shared ambition to continue building WilsonHCG into the global talent solutions leader. Further, 3i’s international network will enable us to continue expanding our already global footprint.

John Wilson , Founder and CEO, WilsonHCG

Regulatory information
This transaction involved a recommendation of 3i Corporation.